HYPROTECAN
LIVE

Serial Number

99751307

Owner

OBI PHARMA, INC.

Attorney

RAN HE

Filing Date

Apr 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

HYPROTECAN Trademark

Serial Number: 99751307

HYPROTECAN is a trademark filed by OBI PHARMA, INC. on April 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

OBI PHARMA, INC. (13 trademarks)

Nankang Software Park
Taipei 11503 , TW

Entity Type: 03

Trademark Details

Filing Date

April 8, 2026

Registration Date

Not Registered

Published for Opposition

September 22, 2026

Goods & Services

Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer; Preparations of microorganisms for medical purposes

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 26, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2026 CNEA
ASSIGNED TO EXAMINER
Aug 18, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 8, 2026 MAFR
NEW APPLICATION ENTERED
Apr 8, 2026 NWAP